Inventor · disambiguated record
Benjamin Pratt
Also filed as: PRATT BENJAMIN · PRATT BENJAMIN ANTHONY
14 granted patents·19 pending applications·38 citations·filing 2006–2024
89Inventor score
Files withAKARNA THERAPEUTICS LTD18DART NEUROSCIENCE CAYMAN LTD4DART NEUROSCIENCE LLC3BOLLU VENKATAIAH2RECURIUM IP HOLDINGS LLC2
Top patents by PatentIndex Score
33 records- 0195US10793577B2Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2018·Granted Oct 6, 2020·11 cites·16 claims
- 0295US10167294B2Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2017·Granted Jan 1, 2019·14 cites·20 claims
- 0384US2025206753A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0483US2025171446A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0581US2024025914A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0680US10233187B2Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2017·Granted Mar 19, 2019·2 cites·19 claims
- 0779US10421759B2Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2017·Granted Sep 24, 2019·1 cites·16 claims
- 0878US11365191B2Substituted cyclohexyl compounds as NOP inhibiiorsDART NEUROSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·2 cites·25 claims
- 0978US2023183247A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1077US2025092024A1Substituted cyclohexyl compounds as nop inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1176US9150572B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Oct 6, 2015·2 cites·3 claims
- 1276US9102674B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Aug 11, 2015·2 cites·35 claims
- 1375US2023002394A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1474US11945808B2Substituted cyclohexyl compounds as NOP inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Apr 2, 2024·0 cites·20 claims
- 1572US9675605B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jun 13, 2017·1 cites·7 claims
- 1670US2021139490A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1770US2021147426A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1869US8785488B2Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesityBOLLU VENKATAIAH·Filed 2010·Granted Jul 22, 2014·3 cites·14 claims
- 1968US2021214362A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2068US2020079782A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2168US2019308977A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2266US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 2362US2025215010A1Diazabicyclooctane derivatives useful as matrix metalloproteinase inhibitorsVASA THERAPEUTICS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA·Filed 2023·Application pending·0 cites
- 2461US2025026761A1Diazabicyclooctane derivatives useful as matrix metalloproteinase inhibitorsVASA THERAPEUTICS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA·Filed 2022·Application pending·0 cites
- 2559US9956213B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted May 1, 2018·0 cites·18 claims
- 2659US2020407364A1Fused bicyclic compoundsAKARNA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2754US8003801B2Chemical synthesis of a highly potent epothiloneSCRIPPS RESEARCH INST·Filed 2006·Granted Aug 23, 2011·0 cites·24 claims
- 2854US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2949US2018346473A1Fused bicyclic compoundsAKARNA THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 3045US2020397798A1Combination therapies with farnesoid x receptor (fxr) modulatorsAKARNA THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3145US2020325140A1Fused bicyclic compounds for the treatment of diseaseAKARNA THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3240US2011301183A1Chemical synthesis of a highly potent epothiloneNICOLAOU KYRIACOS C·Filed 2011·Application pending·0 cites
- 3331US8846739B2TGR5 agonistsBOLLU VENKATAIAH·Filed 2010·Granted Sep 30, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Benjamin Pratt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →